
|Articles|November 13, 2006
SCORE study updates announced
Triamcinolone acetonide injections for macular edema associated with retinal vein occlusion have become a therapeutic mainstay, but conflicting data have emerged about the safety of these injections, and some reports indicate that visual stabilization rather than visual improvement is occurring.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
FDA approves NDA labeling supplement allowing re-administration of iDose TR
4
FDA Type C meeting supports phase 2b/3 pathway for urcosimod in neuropathic corneal pain
5



























